Clinical Trials - HIV/Aids - Upcoming studies

Upcoming HIV/Aids studies

CHRU will be participating in the following clinical trials:

NCT To be confirmed

Protocol number/ title: A randomized, open-label pilot study of potential treatment strategies for non-alcoholic natty liver disease (NAFLD), a metabolic syndrome with insulin resistance, increased hepatic lipids, and increased cardiovascular disease risk.

Principal Investigator (PI) Interventional / Observational Closed/ Ongoing Start/
end date
Network Funders/ sponsors
To be confirmed

NCT To be confirmed

Protocol number/ title: The study looks at pharmacokinetic interactions of Etonogestrel Subdermal Implants (ENG) with Rilpivirine (RPV) Combined with Tenofovir Alafenamide (TAF) and Emtricitabine (FTC).

Principal Investigator (PI) Interventional / Observational Closed/ Ongoing Start/
end date
Network Funders/ sponsors
To be confirmed

NCT To be confirmed

Protocol number/ title: A Phase 1 Clinical Trial of the Safety, Tolerability, and Efficacy of IL-15 Superagonist (N-803) with and without Combination Broadly Neutralizing Antibodies to Induce HIV-1 Control During Analytic Treatment Interruption

PI Interventional / Observational Closed/ Ongoing Start/
end date
Network Funders/ sponsors
To be confirmed.